Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay-Reference-Cited by-同舟云学术

Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay

Published:2016-10 Issue:4 Volume:7 Page:787-801
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Hammoud Lamis,Adams Jessica R.,Loch Amanda J.,Marcellus Richard C.,Uehling David E.,Aman Ahmed,Fladd Christopher,McKee Trevor D.,Jo Christine E.B.,Al-Awar Rima,Egan Sean E.,Rossant Janet

Funder

Canadian Institutes for Health Research

Ontario Institute for Cancer Research

Ontario Institute for Regenerative Medicine

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference70 articles.

1. Therapeutic modulation of Notch signalling—are we there yet?;Andersson;Nat. Rev. Drug Discov.,2014

2. The RSK family of kinases: emerging roles in cellular signalling;Anjum;Nat. Rev. Mol. Cell Biol.,2008

3. Angiogenic morphogenesis driven by dynamic and heterogeneous collective endothelial cell movement;Arima;Development,2011

4. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model;Assis;J. Exp. Clin. Cancer Res.,2015

5. Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2;Bid;Mol. Cancer Ther.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of the Neointimal Hyperplasia-Related LncRNA-mRNA-Immune Cell Regulatory Network in a Rat Carotid Artery Balloon Injury Model;International Heart Journal;2024

2. Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies;Applied Immunohistochemistry & Molecular Morphology;2022-05-20

3. Design, synthesis and anti-breast cancer evaluation of biaryl pyridine analogues as potent RSK inhibitors;Bioorganic & Medicinal Chemistry Letters;2022-03

4. Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling data;Data in Brief;2021-10

5. N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors;Bioorganic & Medicinal Chemistry;2021-07